scholarly journals ADAPTS: Automated Deconvolution Augmentation of Profiles for Tissue Specific cells

2019 ◽  
Author(s):  
Samuel A Danziger ◽  
David L Gibbs ◽  
Ilya Shmulevich ◽  
Mark McConnell ◽  
Matthew WB Trotter ◽  
...  
Keyword(s):  
Gene Expression ◽  
Single Cell ◽  
Gene Expression Data ◽  
Immune Cell ◽  
De Novo ◽  
Cell Types ◽  
Expression Data ◽  
Cell Type ◽  
Data Set ◽  
Rnaseq Data

AbstractImmune cell infiltration of tumors can be an important component for determining patient outcomes, e.g. by inferring immune cell presence by deconvolving gene expression data drawn from a heterogenous mix of cell types. One particularly powerful family of deconvolution techniques uses signature matrices of genes that uniquely identify each cell type as determined from cell type purified gene expression data. Many methods of this type have been recently published, often including new signature matrices appropriate for a single purpose, such as investigating a specific type of tumor. The package ADAPTS helps users make the most of this expanding knowledge base by introducing a framework for cell type deconvolution. ADAPTS implements modular tools for customizing signature matrices for new tissue types by adding custom cell types or building new matrices de novo, including from single cell RNAseq data. It includes a common interface to several popular deconvolution algorithms that use a signature matrix to estimate the proportion of cell types present in heterogenous samples. ADAPTS also implements a novel method for clustering cell types into groups that are hard to distinguish by deconvolution and then re-splitting those clusters using hierarchical deconvolution. We demonstrate that the techniques implemented in ADAPTS improve the ability to reconstruct the cell types present in a single cell RNAseq data set in a blind predictive analysis. ADAPTS is currently available for use in R on CRAN and GitHub.

scholarly journals Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data

eLife ◽  
2017 ◽  
Vol 6 ◽  
Author(s):  
Julien Racle ◽  
Kaat de Jonge ◽  
Petra Baumgaertner ◽  
Daniel E Speiser ◽  
David Gfeller
Keyword(s):  
Gene Expression ◽  
Gene Expression Data ◽  
Immune Cell ◽  
Expression Profiles ◽  
Cell Types ◽  
Response To Therapy ◽  
Expression Data ◽  
Cell Type ◽  
Tumor Gene Expression ◽  
Tumor Gene

Immune cells infiltrating tumors can have important impact on tumor progression and response to therapy. We present an efficient algorithm to simultaneously estimate the fraction of cancer and immune cell types from bulk tumor gene expression data. Our method integrates novel gene expression profiles from each major non-malignant cell type found in tumors, renormalization based on cell-type-specific mRNA content, and the ability to consider uncharacterized and possibly highly variable cell types. Feasibility is demonstrated by validation with flow cytometry, immunohistochemistry and single-cell RNA-Seq analyses of human melanoma and colorectal tumor specimens. Altogether, our work not only improves accuracy but also broadens the scope of absolute cell fraction predictions from tumor gene expression data, and provides a unique novel experimental benchmark for immunogenomics analyses in cancer research (http://epic.gfellerlab.org).

scholarly journals Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data

2017 ◽  
Author(s):  
Julien Racle ◽  
Kaat de Jonge ◽  
Petra Baumgaertner ◽  
Daniel E. Speiser ◽  
David Gfeller
Keyword(s):  
Gene Expression ◽  
Gene Expression Data ◽  
Immune Cell ◽  
Expression Profiles ◽  
Cell Types ◽  
Response To Therapy ◽  
Expression Data ◽  
Cell Type ◽  
Tumor Gene Expression ◽  
Tumor Gene

AbstractImmune cells infiltrating tumors can have important impact on tumor progression and response to therapy. We present an efficient algorithm to simultaneously estimate the fraction of cancer and immune cell types from bulk tumor gene expression data. Our method integrates novel gene expression profiles from each major non-malignant cell type found in tumors, renormalization based on cell-type specific mRNA content, and the ability to consider uncharacterized and possibly highly variable cell types. Feasibility is demonstrated by validation with flow cytometry, immunohistochemistry and single-cell RNA-Seq analyses of human melanoma and colorectal tumor specimens. Altogether, our work not only improves accuracy but also broadens the scope of absolute cell fraction predictions from tumor gene expression data, and provides a unique novel experimental benchmark for immunogenomics analyses in cancer research.

scholarly journals Putative cell type discovery from single-cell gene expression data

2020 ◽  
Vol 17 (6) ◽  
pp. 621-628 ◽  
Author(s):  
Zhichao Miao ◽  
Pablo Moreno ◽  
Ni Huang ◽  
Irene Papatheodorou ◽  
Alvis Brazma ◽  
...  
Keyword(s):  
Gene Expression ◽  
Single Cell ◽  
Gene Expression Data ◽  
Expression Data ◽  
Cell Type ◽  
Cell Gene Expression ◽  
Cell Gene

scholarly journals Bayesian log-normal deconvolution for enhanced in silico microdissection of bulk gene expression data

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Bárbara Andrade Barbosa ◽  
Saskia D. van Asten ◽  
Ji Won Oh ◽  
Arantza Farina-Sarasqueta ◽  
Joanne Verheij ◽  
...  
Keyword(s):  
Gene Expression ◽  
Gene Expression Data ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Cell Types ◽  
Expression Data ◽  
Cell Type ◽  
Expression Variability ◽  
Variable Nature ◽  
Log Normal

AbstractDeconvolution of bulk gene expression profiles into the cellular components is pivotal to portraying tissue’s complex cellular make-up, such as the tumor microenvironment. However, the inherently variable nature of gene expression requires a comprehensive statistical model and reliable prior knowledge of individual cell types that can be obtained from single-cell RNA sequencing. We introduce BLADE (Bayesian Log-normAl Deconvolution), a unified Bayesian framework to estimate both cellular composition and gene expression profiles for each cell type. Unlike previous comprehensive statistical approaches, BLADE can handle > 20 types of cells due to the efficient variational inference. Throughout an intensive evaluation with > 700 simulated and real datasets, BLADE demonstrated enhanced robustness against gene expression variability and better completeness than conventional methods, in particular, to reconstruct gene expression profiles of each cell type. In summary, BLADE is a powerful tool to unravel heterogeneous cellular activity in complex biological systems from standard bulk gene expression data.

scholarly journals BLADE: Bayesian Log-normAl DEconvolution for enhanced in silico microdissection of bulk gene expression data

2020 ◽  
Author(s):  
Bárbara Andrade Barbosa ◽  
Saskia van Asten ◽  
Ji-won Oh ◽  
Arantza Fariña-Sarasqueta ◽  
Joanne Verheij ◽  
...  
Keyword(s):  
Gene Expression ◽  
Gene Expression Data ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Cell Types ◽  
Expression Data ◽  
Cell Type ◽  
Expression Variability ◽  
Variable Nature ◽  
Log Normal

Abstract High-resolution deconvolution of bulk gene expression profiles is pivotal to characterize the complex cellular make-up of tissues, such as tumor microenvironment. Single-cell RNA-seq provides reliable prior knowledge for deconvolution, however, a comprehensive statistical model is required for efficient utilization due to the inherently variable nature of gene expression. We introduce BLADE (Bayesian Log-normAl Deconvolution), a comprehensive probabilistic framework to estimate both cellular make-up and gene expression profiles of each cell type in each sample. Unlike previous comprehensive statistical approaches, BLADE can handle >20 cell types thanks to the efficient variational inference. Throughout an intensive evaluation using >700 datasets, BLADE showed enhanced robustness against gene expression variability and better completeness than conventional methods, in particular to reconstruct gene expression profiles of each cell type. All-in-all, BLADE is a powerful tool to unravel heterogeneous cellular activity in complex biological systems based on standard bulk gene expression data.

scholarly journals Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ikko Mito ◽  
Hideyuki Takahashi ◽  
Reika Kawabata-Iwakawa ◽  
Shota Ida ◽  
Hiroe Tada ◽  
...  
Keyword(s):  
Gene Expression ◽  
T Cells ◽  
Tumor Microenvironment ◽  
Head And Neck ◽  
Gene Expression Data ◽  
Immune Cell ◽  
Cell Types ◽  
Expression Data ◽  
Immune Microenvironment ◽  
Cancer Tissues

AbstractHead and neck squamous carcinoma (HNSCC) is highly infiltrated by immune cells, including tumor-infiltrating lymphocytes and myeloid lineage cells. In the tumor microenvironment, tumor cells orchestrate a highly immunosuppressive microenvironment by secreting immunosuppressive mediators, expressing immune checkpoint ligands, and downregulating human leukocyte antigen expression. In the present study, we aimed to comprehensively profile the immune microenvironment of HNSCC using gene expression data obtained from public database. We calculated enrichment scores of 33 immune cell types based on gene expression data of HNSCC tissues and adjacent non-cancer tissues. Based on these scores, we performed non-supervised clustering and identified three immune signatures—cold, lymphocyte, and myeloid/dendritic cell (DC)—based on the clustering results. We then compared the clinical and biological features of the three signatures. Among HNSCC and non-cancer tissues, human papillomavirus (HPV)-positive HNSCCs exhibited the highest scores in various immune cell types, including CD4+ T cells, CD8+ T cells, B cells, plasma cells, basophils, and their subpopulations. Among the three immune signatures, the proportions of HPV-positive tumors, oropharyngeal cancers, early T tumors, and N factor positive cases were significantly higher in the lymphocyte signature than in other signatures. Among the three signatures, the lymphocyte signature showed the longest overall survival (OS), especially in HPV-positive patients, whereas the myeloid/DC signature demonstrated the shortest OS in these patients. Gene set enrichment analysis revealed the upregulation of several pathways related to inflammatory and proinflammatory responses in the lymphocyte signature. The expression of PRF1, IFNG, GZMB, CXCL9, CXCL10, PDCD1, LAG3, CTLA4, HAVCR2, and TIGIT was the highest in the lymphocyte signature. Meanwhile, the expression of PD-1 ligand genes CD274 and PDCD1LG2 was highest in the myeloid/DC signature. Herein, our findings revealed the transcriptomic landscape of the immune microenvironment that closely reflects the clinical and biological significance of HNSCC, indicating that molecular profiling of the immune microenvironment can be employed to develop novel biomarkers and precision immunotherapies for HNSCC.

scholarly journals Bayesian estimation of cell-type-specific gene expression per bulk sample with prior derived from single-cell data

2020 ◽  
Author(s):  
Jiebiao Wang ◽  
Kathryn Roeder ◽  
Bernie Devlin
Keyword(s):  
Gene Expression ◽  
Single Cell ◽  
Rna Sequencing ◽  
Cell Types ◽  
Autism Spectrum ◽  
Specific Cell ◽  
Expression Data ◽  
Cell Type ◽  
Disease Etiology ◽  
Cell Type Specific

AbstractWhen assessed over a large number of samples, bulk RNA sequencing provides reliable data for gene expression at the tissue level. Single-cell RNA sequencing (scRNA-seq) deepens those analyses by evaluating gene expression at the cellular level. Both data types lend insights into disease etiology. With current technologies, however, scRNA-seq data are known to be noisy. Moreover, constrained by costs, scRNA-seq data are typically generated from a relatively small number of subjects, which limits their utility for some analyses, such as identification of gene expression quantitative trait loci (eQTLs). To address these issues while maintaining the unique advantages of each data type, we develop a Bayesian method (bMIND) to integrate bulk and scRNA-seq data. With a prior derived from scRNA-seq data, we propose to estimate sample-level cell-type-specific (CTS) expression from bulk expression data. The CTS expression enables large-scale sample-level downstream analyses, such as detecting CTS differentially expressed genes (DEGs) and eQTLs. Through simulations, we demonstrate that bMIND improves the accuracy of sample-level CTS expression estimates and power to discover CTS-DEGs when compared to existing methods. To further our understanding of two complex phenotypes, autism spectrum disorder and Alzheimer’s disease, we apply bMIND to gene expression data of relevant brain tissue to identify CTS-DEGs. Our results complement findings for CTS-DEGs obtained from snRNA-seq studies, replicating certain DEGs in specific cell types while nominating other novel genes in those cell types. Finally, we calculate CTS-eQTLs for eleven brain regions by analyzing GTEx V8 data, creating a new resource for biological insights.

scholarly journals Immuno-Navigator, a batch-corrected coexpression database, reveals cell type-specific gene networks in the immune system

2016 ◽  
Vol 113 (17) ◽  
pp. E2393-E2402 ◽  
Author(s):  
Alexis Vandenbon ◽  
Viet H. Dinh ◽  
Norihisa Mikami ◽  
Yohko Kitagawa ◽  
Shunsuke Teraguchi ◽  
...  
Keyword(s):  
Gene Expression ◽  
Immune System ◽  
Gene Expression Data ◽  
Cell Types ◽  
Treg Cells ◽  
Integrated Analysis ◽  
Expression Data ◽  
Batch Effects ◽  
Cell Type ◽  
Cell Type Specific

High-throughput gene expression data are one of the primary resources for exploring complex intracellular dynamics in modern biology. The integration of large amounts of public data may allow us to examine general dynamical relationships between regulators and target genes. However, obstacles for such analyses are study-specific biases or batch effects in the original data. Here we present Immuno-Navigator, a batch-corrected gene expression and coexpression database for 24 cell types of the mouse immune system. We systematically removed batch effects from the underlying gene expression data and showed that this removal considerably improved the consistency between inferred correlations and prior knowledge. The data revealed widespread cell type-specific correlation of expression. Integrated analysis tools allow users to use this correlation of expression for the generation of hypotheses about biological networks and candidate regulators in specific cell types. We show several applications of Immuno-Navigator as examples. In one application we successfully predicted known regulators of importance in naturally occurring Treg cells from their expression correlation with a set of Treg-specific genes. For one high-scoring gene, integrin β8 (Itgb8), we confirmed an association between Itgb8 expression in forkhead box P3 (Foxp3)-positive T cells and Treg-specific epigenetic remodeling. Our results also suggest that the regulation of Treg-specific genes within Treg cells is relatively independent of Foxp3 expression, supporting recent results pointing to a Foxp3-independent component in the development of Treg cells.

Sign in / Sign up

Export Citation Format

Share Document